SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|
abx137719-100tests |
Abbexa |
100 tests |
EUR 1237.5 |
Human IgG antibody Laboratories manufactures the sars cov spike antibody reagents distributed by Genprice. The Sars Cov Spike Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Sars products are available in stock. Specificity: Sars Category: Cov Group: Spike Antibody
Spike Antibody information
SARS-CoV Spike Antibody |
|
MBS9457580-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3560 |
SARS-CoV Spike Antibody |
|
MBS9457581-005mL |
MyBiosource |
0.05mL |
EUR 530 |
SARS-CoV Spike Antibody |
|
MBS9457581-01mL |
MyBiosource |
0.1mL |
EUR 825 |
SARS-CoV Spike Antibody |
|
MBS9457581-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3560 |
SARS-CoV Spike Antibody |
|
MBS9457582-005mL |
MyBiosource |
0.05mL |
EUR 530 |
SARS-CoV Spike Antibody |
|
MBS9457582-01mL |
MyBiosource |
0.1mL |
EUR 825 |
SARS-CoV Spike Antibody |
|
MBS9457582-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3560 |
SARS-CoV Spike Antibody |
|
21807 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
21808 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
21809 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
21810 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
21811 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
21812 |
SAB |
100ul |
EUR 1039 |
SARS-CoV Spike Antibody |
|
3219-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|
3219-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|
3221-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|
3221-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |